SCHEMBL8104154

SCHEMBL8104154

CS(=O)(=O)C1CC(=O)N1CCCCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.44
SIGMAR1 Q99720 7/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.41
CCR3 P51677 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR2A P28223 1/20 0.39
KCNH2 Q12809 1/20 0.39
NAAA Q02083 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8439355 0.84 GSK3A (0.44) FAAHMGLLSIGMAR1GSK3AGSK3B
SCHEMBL8104121 0.81 MAPT (0.43) FAAHNAAA
SCHEMBL8110094 0.81 MAPT (0.43) FAAHNAAA
SCHEMBL8094843 0.81 EHMT2 (0.45) POLBMEN1TSHRKMT2A
SCHEMBL8110081 0.81 HDAC3 (0.41) FAAHTDP1POLBMEN1KMT2A
SCHEMBL8772476 0.79 ALDH1A1 (0.46) SIGMAR1TDP1L3MBTL1POLBCYP3A4
SCHEMBL8104169 0.79 TRPV1 (0.50) L3MBTL1POLBTSHRKMT2A
SCHEMBL8772449 0.78 CYP1A2 (0.42) GSK3AGSK3BTDP1L3MBTL1POLB
SCHEMBL8623161 0.78 GSK3B (0.39) FAAHMGLLSIGMAR1GSK3AGSK3B
SCHEMBL8772454 0.78 POLB (0.42) SIGMAR1GSK3AGSK3BTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6071899-A Azetidinone derivatives for the treatment of atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2000-06-06 US claimed
EP-0788478-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-08-13 EP claimed
WO-1996013484-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-05-09 WO claimed
US-6071899-A Azetidinone derivatives for the treatment of atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2000-06-06 US disclosed